Well FMrick, I have to disagree with you. There are a few new trials and publications of Tesetaxel that will be presented at ASCO. The ATG trial was updated and the results were very positive. Overall, these abstracts produced very promising results for this small company. Yes, those other companies did have great results, but then again they are $50 stocks+
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.